诊断相关分组耐药菌院内感染及经济负担分析  

Analysis on nosocomial infection of drug-resistant bacteriaunder the DRGs and economic burden

作　　者：潘红平[1] 杨波[1] 朱鸿娟 周媛[2] 董正娇 杨静 陈丽红[1] 梁超[1] PAN Hongping;YANG Bo;ZHU Hongjuan;ZHOU Yuan;DONG Zhengjiao;YANG Jing;CEHN Lihong;LIANG Chao(Department of Nosocomial Infection Management,Yuxi People's Hospital/Sixth Affiliated Hospital of Kunming Medical University,Yuxi Yunnan 653100,China;Pharmacy Department,Yuxi People's Hospital/Sixth Affiliated Hospital of Kunming Medical University,Yuxi Yunnan 653100,China)

机构地区：[1]玉溪市人民医院/昆明医科大学第六附属医院医院感染管理部,云南玉溪653100 [2]玉溪市人民医院/昆明医科大学第六附属医院药学部,云南玉溪653100

出　　处：《云南医药》2024年第4期83-86,共4页Medicine and Pharmacy of Yunnan

基　　金：云南省教育厅科学研究基金(2023J0387)。

摘　　要：目的分析基于DRGs的MDRO医院感染情况与经济负担,为MDRO防控提供依据。方法回顾性分析本院2021年1月-2021年12月MDRO感染情况,将DRGs同组患者分为MDRO医院感染组和非MDRO感染组,分析2组患者住院时间及住院费用。结果2021年住院患者共入组DRGs病例73150例,发生MDRO医院感染188例,感染率为0.26%。MDRO医院感染DRGs组数占全院总DRGs组数的11.64%,下呼吸道感染位居第一位。MDRO医院感染组较非MDRO感染组住院时间延长14.5d,住院总费用增加47188.03元,医疗费、医技费、护理费、药品费、耗材费、抗菌药物费、输血费等MDRO医院感染组均高于非MDRO感染组差异有统计学意义(P<0.001)。结论由DRGs支付的患者医治数据可知易感染MDRO的患者及其所在科室和大幅增加的医治费用,相关部门适时关注DRGs支付情况,及时采取针对性措施,则可降低患者MDRO感染率和经济负担。Objective To analyze nosocomial infection of multidrug-resistant organism(MDRO)under the DRGs and economic burden,so as to provide basis for prevention and control of MDRO.Methods Retrospectively analyzee MDRO infection in our hospital in 2021,the patients in the DRGs group were divided into MDRO hospital infection group and non-NDRO infection group,and the hospital stay and hospitalization cost of the two groups were analyzed.Results In 2021,there were a total of 73,150 hospitalized patients of DRGs and a total of 188 cases MDRO nosocomial infection occurred,with an infection rate of 0.26%.The number of hospital infection DRGs in MDRO accounted for 11.64%of the total number of DRGs in the hospital,and lower respiratory tract infection ranked first.Tthe hospitalization time of the MDRO group with hospital infection was 14.5days longer than that of non-MDRO group,and the total hospitalization cost increased by 47188.03 RMB.The cost of medical treatment,medical technology,nursing care,drugs,consumables,antibacterial drugs,blood transfusion and other costs in the MDRO group were higher than those in the non-MDRO group(P<0.001).Conclusions According to the patient treatment data under the DRGs payment,we can know the patients who are susceptible to MDRO infection and the departments where the infected patients are located,as well as the greatly increased medical costs.Relevant departments should pay attention to the payment of DRGs at the right time and take timely targeted measures,which can reduce the infection rate and economic burden of patients with MDRO.

关 键 词：诊断相关分组 医院感染 多重耐药菌 经济负担 

分 类 号：R197.323[医药卫生—卫生事业管理]